Halozyme Therapeutics shares owned by Citigroup
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Citigroup
from 13F filings
Historical chart of Citigroup investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Citigroup consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Citigroup
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $11M | 10M | 1.04 |
| 2025-03-31 | $4.2M | 3.9M | 1.06 |
| 2024-12-31 | $13k | 14k | 0.95 |
| 2024-06-30 | $20M | 21M | 0.95 |
| 2024-03-31 | $21M | 23M | 0.88 |
| 2023-12-31 | $18M | 21M | 0.86 |
| 2023-09-30 | $18M | 21M | 0.84 |
| 2023-03-31 | $17M | 21M | 0.85 |
| 2022-12-31 | $20M | 20M | 0.97 |
| 2022-09-30 | $17M | 21M | 0.85 |